Product Details for: Sogroya
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
10MG/1.5ML (6.7MG/ML)
Autoinjector
351(a)
Sogroya
Rx
002
Injection
Subcutaneous
5MG/1.5ML (3.3MG/ML)
Autoinjector
351(a)
Sogroya
Rx
003
Injection
Subcutaneous
15MG/1.5ML (10MG/ML)
Autoinjector
351(a)
Sogroya
Rx
Proper Name
somapacitan-beco
somapacitan-beco
BLA Number
761156
761156
Applicant
Novo Nordisk Inc.
Novo Nordisk Inc.
Original Approval Date
August 28, 2020
August 28, 2020
Date of First Licensure